Terran receives FDA clearance for MRI platform
AuntMinnie
DECEMBER 20, 2023
Food and Drug Administration (FDA) clearance to market its NM-101 AI platform for the analysis of neuromelanin-sensitive MRI scans. The platform allows doctors to send neuromelanin MRI images to Terran directly through the hospital picture archiving and communication system and receive a full report back in under an hour, the company said.
Let's personalize your content